MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Balance Sheets Overview

Current Ratio
677.23%
Quick Ratio
643.95%
Cash Ratio
337.57%
Debt to Asset Ratio
97.85%
Unit: Thousand (K) dollars
Assets Breakdown
    • Cash and cash equivalents
    • Short-term investments
    • Accounts receivable, net
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Royalty interest financing liabi...
    • Others
Balance Sheets
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Cash and cash equivalents
336,477
130,893
134,930
116,808
Short-term investments
211,383
221,171
259,140
319,171
Accounts receivable, net
45,067
38,116
37,996
25,403
Inventory, net
-
-
32,754
-
Inventory
33,164
34,948
-
25,000
Short-term deposits
6,406
9,175
19,616
18,195
Other receivable, net
2,703
267
6,404
0
Collaboration receivable, net
22,359
20,507
23,745
15,736
Prepaid expenses and other current assets
17,480
16,100
13,496
9,517
Total current assets
675,039
471,177
528,081
529,830
Long-term investments
27,217
-
0
20,146
Property and equipment, gross
646
606
606
-
Accumulated depreciation
434
429
425
-
Property and equipment, net
212
177
181
128
Right-of-use asset, net
1,082
1,212
1,342
1,471
Restricted cash
102
102
102
217
Total assets
703,652
472,668
529,706
551,792
Accounts payable
4,874
10,843
16,580
13,826
Collaboration payable, net
-
-
0
0
Accrued expenses and other current liabilities
94,297
74,843
103,064
77,105
Current portion of royalty interest financing liability
-
-
-
22,925
Current portion of royalty interest financing
-
-
0
-
Current portion of right-of-use liability
506
487
470
329
Current portion of capital lease
0
1
2
2
Total current liabilities
99,677
86,174
120,116
114,187
Royalty interest financing liability, less current portion
344,026
343,965
-
320,985
Royalty interest financing, less current portion
-
-
343,909
-
Convertible note liability
244,090
-
-
-
Right-of-use liability, less current portion
760
907
1,051
1,190
Total long-term liabilities
588,876
344,872
344,960
322,175
Total liabilities
688,553
431,046
465,076
436,362
Common stock, 0.0001 par value, 200,000,000 shares authorized 89,150,619 and 87,405,979 shares issued and outstanding at june 30, 2026 and december 30, 2025, respectively
9
9
9
9
Additional paid-in capital
1,613,846
1,590,855
1,570,749
1,553,462
Accumulated other comprehensive (loss) gain
-140
11
452
525
Accumulated deficit
-1,598,616
-1,549,253
-1,506,580
-1,438,566
Total stockholders equity
15,099
41,622
64,630
115,430
Total liabilities and stockholders equity
703,652
472,668
529,706
551,792
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Cash and cashequivalents$336,477K (209.73%↑ Y/Y)Short-term investments$211,383K (-39.01%↓ Y/Y)Accounts receivable, net$45,067K (131.66%↑ Y/Y)Inventory$33,164K (87.41%↑ Y/Y)Collaboration receivable, net$22,359K (81.54%↑ Y/Y)Prepaid expenses andother current assets$17,480K (77.01%↑ Y/Y)Short-term deposits$6,406K (-52.45%↓ Y/Y)Other receivable, net$2,703K (-25.52%↓ Y/Y)Property and equipment,gross$646K Total current assets$675,039K (26.96%↑ Y/Y)Long-term investments$27,217K (-56.54%↓ Y/Y)Right-of-use asset, net$1,082K (-33.58%↓ Y/Y)Property and equipment,net$212K Restricted cash$102K (-53.00%↓ Y/Y)Accumulated depreciation$434K Total assets$703,652K (18.03%↑ Y/Y)Total liabilities andstockholders equity$703,652K (18.03%↑ Y/Y)Total liabilities$688,553K (56.94%↑ Y/Y)Total stockholdersequity$15,099K (-90.41%↓ Y/Y)Accumulated deficit-$1,598,616K (-16.02%↓ Y/Y)Accumulated othercomprehensive (loss) gain-$140K (-149.12%↓ Y/Y)Total long-termliabilities$588,876K (80.78%↑ Y/Y)Total currentliabilities$99,677K (-11.78%↓ Y/Y)Additional paid-in capital$1,613,846K (5.14%↑ Y/Y)Common stock, 0.0001par value,...$9K (0.00%↑ Y/Y)Royalty interestfinancing liability, less...$344,026K (6.05%↑ Y/Y)Convertible note liability$244,090K Right-of-use liability, lesscurrent portion$760K (-42.64%↓ Y/Y)Accrued expenses andother current...$94,297K (32.69%↑ Y/Y)Accounts payable$4,874K (-71.91%↓ Y/Y)Current portion ofright-of-use liability$506K (47.09%↑ Y/Y)

Syndax Pharmaceuticals Inc (SNDX)

Syndax Pharmaceuticals Inc (SNDX)